Vitamin E deficiency and risk of equine motor neuron disease

Acta Veterinaria Scandinavica

Volumn 49, Issue 1, 2007, Pages

  Mohammed, Hussni O ^a   Divers, Thomas J ^a   Summers, Brian A ^b   De Lahunta, Alexander ^a  

^a Department of Obstetrics Gynecology   (United States)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; EQUIDAE;

ALPHA TOCOPHEROL;

ALPHA TOCOPHEROL DEFICIENCY; ANIMAL; ANIMAL DISEASE; ANIMAL FOOD; ARTICLE; BLOOD; BREEDING; FEMALE; HORSE; HORSE DISEASE; MALE; MOTOR NEURON DISEASE; RISK FACTOR;

ANIMAL NUTRITION PHYSIOLOGY; ANIMALS; BREEDING; FEMALE; HORSE DISEASES; HORSES; MALE; MOTOR NEURON DISEASE; RISK FACTORS; VITAMIN E; VITAMIN E DEFICIENCY;

EID: 34548129209     PISSN: 0044605X     EISSN: None     Source Type: Journal    
DOI: 10.1186/1751-0147-49-17     Document Type: Article

References (49)

1. Hereditary canine spinal muscular atrophy. LC Cork JW Griffin JF Munnell MD Lorenz RJ Adams, J Neuropathol Exp Neurol 1979 38 209 221 438862
2. Spinal muscular atrophy in Brown Swiss calves. M el-Hamidi HW Leipold JG Vestweber G Saperstein, Zentralbl Veterinarmed A 1989 36 731 738 2515682
3. Spontaneous lower motor neuron disease with neurofibrillary accumulation in young pigs. RJ Higgins DM Rings WR Fenner S Stevenson, Acta Neuropathol (Berl) 1983 59 288 294 10.1007/BF00691495 6683455
4. Equine motor neuron disease: a preliminary report. JF Cummings C George A de Lahunta L Fuher BA Valentine BJ Cooper BA Summers CK Huxtable HO Mohammed, Cornell Vet 1990 80 357 379 2209016
5. Equine motor neuron disease in twenty-six horses. TJ Divers HO Mohammed JF Cummings BA Valentine A de Lahunta BA Summers K Trembicki-Graves, Equine Vet J 1994 26 409 415 7988544
6. The central nervous system in motor neuron disease. B Brownell DR Oppenheimer JT Hughes, J Neurol Neurosurg Psychiat 1984 33 3 338 357 5431724
7. Neuropathology of ALS. An overview. A Hirano, Neurology 1996 47 4 Suppl 2 S63 66 8858053
8. Amyotrophic lateral sclerosis. T Lawyer MG Netsky, Arch Neurol 1953 69 2 171 192 13007227
9. Morphometric studies on equine motor neuron disease. EW Polack JF Cummings J King HO Mohammed, Equine Vet J 1998 30 255 259
10. Intrinsic, management, and nutritional factors associated with equine motor neuron disease. R de la Rua-Domenech HO Mohammed JF Cummings TJ Divers A de Lahunta BA Summers, Am J Vet Res 1997 211 10 1261 1267 9373362
11. Risk factors associated with equine motor neuron disease: A possible ALS model. HO Mohammed JF Cummings TJ Divers A de Lahunta C George L Fuhrer BA Valentine BA Summers BRH Farrow K Trembicki A Mauskopf, Neurology 1993 43 966 971 8492954
12. Epidemiologic evidence for clustering of equine motor neuron disease in the U.S. R de la Rua-Domenech HO Mohammed JF Cummings TJ Divers A de Lahunta B Valentine BA Summers C Jackson, Am J Vet Res 1995 56 1433 1439 8585652
13. Equine motor neuron disease. TJ Divers HO Mohammed JF Cummings, Veterinary Clinic of North America 1997 13 97 105 9106346
14. Association between plasma vitamin E concentrations and the risk of equine motor neuron disease. R de la Rua-Domenech HO Mohammed JF Cummings TJ Divers A de Lahunta BA Summers, Brit Vet J 1997 154 203 213 10.1016/S1090- 0233(97)80021-4
15. Epidemiologic correlates of sporodic amyotrophic lateral sclerosis. C Armon LT Kurland JR Daube PC O'Brien, Neurology 1991 41 1077 1084 2067636
16. Equine motor neuron disease and diet high in iron and copper. TJ Divers A de Lahunta S Hintz HO Mohammed, Am J Vet Res 2005 67 120 126 10.2460/ajvr.67.1.120
17. Ocular manifestations of equine motor neuron disease. RC Riis C Jackson W Rebhun ML Katz E Loew AB Summers JF Cummings A de Lahunta TJ Divers HO Mohammed, Equine Vet J 1999 31 99 110 10213421
18. Endothelial lipopigment as an indicator of a tocopherol deficiency in two equine neurodegenerative diseases. JF Cummings A de Lahunta HO Mohammed TJ Divers BA Summers BA Valentine CA Jackson, Acta Neuropath 1995 90 266 272 8525800
19. Equine degenerative myeloencephalopathy: a vitamin E deficiency that may be familial. G Mayhew CW Brown HD Stowe AL Trapp FJ Derksen SF Clement, J Vet Int Med 1987 1 45 49
20. Progressive neuropathologic lesions in vitamin E deficient Rhesus monkeys. JS Nelson CD Fitch VW Fischer GO Broun AC Shou, J Neuropath Exp Neurology 1981 40 2 166 186
21. Dinitrophenyl hydrazine method. C Burtis E Ashwood eds, Tietz. Textbook of clinical chemistry W.B. Saunders 2 1994 1313 1314
22. Studies on the quantitative and qualitative characterisation of erythrocyte glutathione peroxidase. DE Paglia WN Valenrine, J Lab Clin Med 1967 70 158 69 6066618
23. Determination of Superoxide Dismutase Activity by Purely Chemical System Based on NAD(P)H Oxidation. F Paoletti A Mocali, Methods in Enzymology 1990 186 209 220 2233293
24. Nonparameteric estimation from incomplete observations. EL Kaplan P Meier, J Am Stat Assoc 1958 53 457 481 10.2307/2281868
25. Cloning and sequence analysis of the equine CU/Zn super oxide dismutase cDNA and its relationship with equine motor neuron disease. R de la Rua-Domenech M Wiedman HO Mohammed JF Cummings TJ Divers CA Batt, Gene 1996 178 83 88 10.1016/0378-1119(96)00339-3 8921896
26. Methods in Observational Epidemiology. Monograph in Epidemiology and Biostatistics. JL Kelsey AS Whitmore AS Evans WD Thompson, Oxford University Press: New York 1996 10
27. Neuropathological studies of chronic vitamin E deficiency in mammals including humans. JS Nelson, Biology of Vitamin E. CIBA Symposium London, E. Pitman Book 1983 101 92 105
28. Decrease in Cu/Zn- and Mn-superoxide dismutase activities in brain and spinal cord of patients with amyotrophic lateral sclerosis. M Uchino Y Ando Y Tanaka T Nakamura E Uyama S Mita T Murakami M Ando, J Neurol Sci 1994 127 61 67 10.1016/0022-510X(94)90136-8 7699393
29. Vitamin E and neurological function. DPR Muller JK Lloyd OH Wolff, Lancet 1983 1 225 228 10.1016/S0140-6736(83)92598-9 6130255
30. Evaluation of antioxidants, protein, and lipid oxidation products in blood from sporadic amyotrophic lateral sclerosis patients. PI Oteiza OD Uchitel F Carrasquedo AL Dubrovski JC Roma CG Fraga, Neurochem Res 1997 22 535 539 10.1023/A:1027384432715 9130267
31. Free radicals, antioxidants, and human disease: curiosity, cause or consequence. B Halliwell, The Lancet 1994 344 721 724 10.1016/S0140-6736(94) 92211-X
32. Oxidative stress; its role in the pathogenesis of amyotrophic lateral sclerosis. C Bergeron, J Neurol Sci 1995 129 81 84 10.1016/0022-510X(95)00071-9 7595629
33. Oxidative stress and motor neurone disease. MR Cookson PJ Shaw, Brain Pathol 1999 9 165 86 9989458
34. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amytrophic lateral sclerosis. ME Gurney FB Cutting P Hhai A Doble P Taylor PK Andrus ED Hall, Ann Neurol 1996 39 147 157 10.1002/ana.410390203 8967745
35. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. DR Rosen T Siddique D Patterson DA Figlewicz P Sapp A Hentati D Donaldson J Goto JP O'Regan HX Deng Z Rahmani A Krizus D McKenna-Yasek A Cayabyab SM Gaston R Berger R Tanzi JJ Halperin B Herzfeldt R Van den Berg W Hung T Bird G Deng DW Mulder C Smyth NG Laing E Soriano MA Pericak-Vance J Haines G Rouleau JF Gusella HR Horvitz RH Brown, Nature 1993 362 59 62 10.1038/362059a0 8446170
36. Motor neuron degeneration in mice expressing a human Cu, Zn superoxide dismutase mutation. ME Gurney H Pu AY Chiu MC Dal Canto CY Polchow DD Alexander J Caliendo A Hentati YW Kwon HX Deng W Chen P Zhai RL Sufit T Siddique, Science 1994 264 1772 1774 10.1126/science.8209258 8209258
37. Motor neuron-astrocyte interactions and levels of Cu, Zn superoxide dismutase in sporadic amyotrophic lateral sclerosis. SA O'Reilly J Roedica D Nagy RA Hallewell K Alderson SL Marklund J Kuby PD Kushner, Exp Neurol 1995 131 203 10 10.1016/0014-4886(95)90042-X 7895821
38. Environmental risk factors for amyotrophic lateral sclerosis. C Armon, Neuroepidemiology 2001 20 2 6 10.1159/000054751 11174039
39. Vitamin E in humans: demand and delivery. MG Traber H Seis, Annu Rev Nutr 1996 16 321 347 [Sies in the text] 10.1146/annurev.nu.16.070196.001541 8839930
40. Blood oxidativestress in amytrophic lateral sclerosis. D Bonnefont-Rousselot L Lacomblez M-C Jaudon S Lepage F Salachas G Bensimon C Bizard V Doppler J Delattre V Meininger, J Neuro Sci 2000 178 57 62 10.1016/S0022-510X(00)00365-8
41. Cerebrospinal fluid levels of alpha-tocopherol in amytrophic lateral sclerosis. F de Bustos FJ Jimenez-Jimenez JA Molina J Esteban A Guerrero-Sola M Zurdo M Orti-Pareja A Tallon-Barranco C Gomez-Escalonilla C Ramirez-Ramos J Arenas R Enriquez de Salamanca, J Neural Transm 1998 105 703 708 10.1007/s007020050089 9826112
42. Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS. ED Hall PK Andrus JA Oostveen TJ Fleck ME Gurney, J Neurosci Res 1998 53 66 77 10.1002/(SICI)1097-4547(19980701)53:1<66::AID-JNR7>3.0.CO;2-H 9670993
43. Effects of a prolonged vitamin E deficiency in the rat. LJ Machlin R Filipski J Nelson LR Horn M Brin, J Nutr 1997 107 1200 1208 874563
44. Recovery in amyotorphic lateral sclerosis. IS Wechsler, Neurology 1940 114 948 950
45. Therapeutic trial in amyotrophic lateral sclerosis. JD Dorman WK Engel DM Fried, J Am Med Assoc 1969 209 757 758 5819233
46. Vitamin E intake and quality of life in amyotrophic lateral sclerosis patients :a follow-up case series study. A Galbussera L Tremolizzo L Brighina D Testa R Lovati C Ferrarese G Cavaletti G Filippini, Neurol Sci 2006 27 190 193 10.1007/s10072-006-0668-x 16897634
47. Serum levels of beta-carotene, alpha-carotene, and vitamin A in patients with amyotrophic lateral sclerosis. JA Molina F de Bustos FJ Jimenez-Jimenez J Esteban A Guerrero-Sola M Zurdo M Orti-Pareja T Gasalla C Gomez-Escalonilla C Ramirez-Ramos FG Guillamon J Arenas, Acta Neurol Scand 1999 99 315 317 10348162
48. Glutathione peroxidase in amyotrophic lateral sclerosis: the effects of selenium supplementation. SZ Apostolski Z Marinkovic A Nikolic D Blagojevic MB Spasic AM Michelson, J Environ Pathol Toxicol Oncol 1998 17 325 329 9726810
49. Horses on pasture may be affected by equine motor neuron disease. BC McGorum IG Mayhew H Amory P Deprez L Gillies K Green TS Mair H Nollet ID Wijnberg CN Hahn, Equine Vet J 2006 38 47 51 10.2746/042516406775374207 16411586